Literature DB >> 15375314

Clinical studies of antisense oligonucleotides for cancer therapy.

Rosanne M Orr1, F Andrew Dorr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15375314     DOI: 10.1385/1-59259-854-4:085

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


× No keyword cloud information.
  2 in total

1.  Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.

Authors:  Lin Zhu; Zhaoyang Ye; Kun Cheng; Duane D Miller; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2007-09-13       Impact factor: 4.774

2.  Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains.

Authors:  Martin Augsten; Anika Böttcher; Rainer Spanbroek; Ignacio Rubio; Karlheinz Friedrich
Journal:  Cell Commun Signal       Date:  2014-01-02       Impact factor: 5.712

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.